Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Stopped Terminated due to inadequate rate of accrual.
Conditions
- Ovarian Cancer
- Epithelial Ovarian Cancer
- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma
Interventions
- DRUG: Lenalidomide, Liposomal Doxorubicin, Bevacizumab
- DRUG: Revlimid, Doxil, Avastin
Sponsor
New Mexico Cancer Research Alliance
Collaborators